$ACHN Headlines U.S. stock futures sink on shutdown fears

New Post Public Reply Private Reply Replies (0) Message Board

Jan 23, 2014 at 10:00 PM

$ACHN Headlines

U.S. stock futures sink on shutdown fears 7:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 4:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 4:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 2:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 4:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 8:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 9:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 9:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 9:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 11:56 a.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 4:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy
Gilead shares boosted by Bristol-Myers drug news 10:24 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Bristol-Myers falls 7% on hepatitis C drug setback 9:09 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Stocks to watch Thursday: Annie’s, Rite Aid 4:02 p.m. June 6, 2012 - David B. Wilkerson
Achillion's chief medical officer resigns 3:19 p.m. June 6, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 3:23 p.m. May 21, 2012 - MarketWatch
Achillion jumps on hepatitis C study 2:22 p.m. May 21, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:26 p.m. April 19, 2012 - MarketWatch

Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 5:27 a.m. Jan. 13, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape 9:04 a.m. Jan. 9, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
Exelixis (EXEL) Jumps: Stock Moves 11.1% Higher - Tale of the Tape 9:25 a.m. Jan. 7, 2014 - Zacks.com
Athersys (ATHX) in Focus: Stock Moves 6.3% Higher - Tale of the Tape 9:04 a.m. Jan. 7, 2014 - Zacks.com
AxoGen (AXGN) in Focus: Stock Surges 25.0% - Tale of the Tape 9:46 a.m. Jan. 2, 2014 - Zacks.com
Commit To Buy Achillion Pharmaceuticals At $2.50, Earn 24% Using Options 11:08 a.m. Dec. 31, 2013 - TheStreet.com
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Top Insider Trades: SIGM, GBDC, ADC, ACHN 5:05 p.m. Dec. 25, 2013 - TheStreet.com
Good Luck Chasing Celldex 6:00 a.m. Dec. 18, 2013 - TheStreet.com
Agenus (AGEN) Soars: Stock Adds 12.7% in Session - Tale of the Tape 9:04 a.m. Dec. 17, 2013 - Zacks.com
Can Achillion Pharmaceuticals (ACHN) Continue to Surge? - Tale of the Tape 8:55 a.m. Dec. 12, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at Oppenheimer 24th Annual Healthcare Conference Transcript 6:19 p.m. Dec. 11, 2013 - Seeking Alpha
7 Biotechnology Stocks to Sell Now 4:00 a.m. Dec. 11, 2013 - InvestorPlace.com
Bad News Biotechs Of 2013 7:00 a.m. Dec. 10, 2013 - Seeking Alpha
Achillion Pharmaceuticals, Inc. (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape 7:41 a.m. Dec. 5, 2013 - Zacks.com
Achillion Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 6:30 p.m. Dec. 4, 2013 - Seeking Alpha
BioDelivery Sciences (BDSI) in Focus: Stock Adds 10.9% in Session - Tale of the Tape 8:37 a.m. Dec. 4, 2013 - Zacks.com
7 Biotechnology Stocks to Sell Now 5:15 a.m. Dec. 4, 2013 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:38 a.m. Dec. 2, 2013 - benzinga.com

Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones 6:25 a.m. Jan. 13, 2014 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 11:53 a.m. Dec. 6, 2013 - PR Newswire
Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Dec. 4, 2013 - PR Newswire
ACHN, CTIC, DRYS and FREE added to NASDAQ Active Stock Watch List at GSR 10:01 a.m. Dec. 2, 2013 - ACCESSWIRE
Achillion to Present at the Three Upcoming Healthcare Conferences 4:05 p.m. Nov. 26, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 1:21 p.m. Nov. 22, 2013 - BusinessWire
SAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Achillion Pharmaceutical, Inc. and Certain Officers - ACLN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 3:58 p.m. Nov. 13, 2013 - GlobeNewswire
Achillion Reiterates HCV Pipeline Priorities and Reports Third Quarter and Nine Month 2013 Financial Results 6:05 a.m. Nov. 12, 2013 - GlobeNewswire
Achillion to Present at the Credit Suisse Healthcare Conference 4:05 p.m. Nov. 11, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Investors with More Than $150,000 in Losses from Investments in Achillion Pharmaceuticals, Inc. Are Encouraged to Contact Wolf Haldenstein before the December 9, 2013 Lead Plaintiff Deadline 12:38 p.m. Nov. 7, 2013 - BusinessWire
Achillion's Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile 8:05 a.m. Nov. 2, 2013 - GlobeNewswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Achillion Pharmaceuticals, Inc. 8:01 a.m. Oct. 31, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Achillion Pharmaceutical, Inc. of Class Action Lawsuit and Upcoming Deadline -- ACLN 1:54 p.m. Oct. 25, 2013 - GlobeNewswire
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN 10:40 a.m. Oct. 25, 2013 - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit on Behalf of Achillion Pharmaceuticals, Inc. Investors 3:12 p.m. Oct. 24, 2013 - BusinessWire
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Achillion Pharmaceuticals, Inc. 11:05 a.m. Oct. 17, 2013 - PR Newswire
AGNC, ACHN, MNKD and ACAD added to NASDAQ Active Stock Watch List at EPR 8:24 a.m. Oct. 15, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Leadership Amidst Rapid Growth Surge

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Puori Protein Transparency Pays Off Amid Lead Scare

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

FCS Drives Key FDA Approvals in Cancer Treatment

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Cogent Communications' Q3 2026 Earnings Call Details

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

Marshall Goldman Expands Footprint with Marino Acquisition

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Tessa AI: Revolutionizing Biomedical Research with AI

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Jaguar Promise Tackles College Cost for Texas Students

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Vayo Debuts as Booking Holdings Eyes $100M Investment

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

JiMMYBAR! Unveils World's First Creatine Trail Mix

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....